What we’re reading, December 12, 2016: veterans with dementia who used both the Department of Veterans Affairs healthcare system and Medicare were more likely to be prescribed potentially unsafe medications; HHS will begin to conduct on-site privacy compliance audits in 2017; study finds that women with strong social connections have better breast cancer outcomes.
A study published in the Annals of Internal Medicine examined the risk of unsafe medication prescribing for veterans with dementia receiving care from the Veterans Affairs (VA) healthcare system, some of whom also used Medicare Part D. The dual VA-Medicare users had more than double the odds of exposure to any potentially unsafe medication, with an adjusted average of 44.1 additional days of exposure compared to the VA-only users. The study authors wrote that “receipt of prescription medications across unconnected systems of care may increase the risk for unsafe prescribing.”
The HHS Office for Civil Rights will begin conducting a “small number of on-site audits in 2017” to ensure compliance with the Health Insurance Portability and Accountability Act (HIPAA), according to an official. Senior advisor Linda Sanches said the agency is “looking for evidence that [providers] are implementing the policies and procedures” designed to protect patient privacy. The HIPAA audits were supposed to begin last year, but HHS did not release its phase 2 audit protocol until this spring.
Outcomes for women who had been diagnosed with breast cancer varied based on the size of their social networks, according to a study published in Cancer. Socially isolated women had higher risks of breast cancer recurrence, breast cancer-specific mortality, and total mortality than women with larger social networks. Specifically, higher breast cancer-specific mortality was predicted by the lack of a spouse/partner or community ties for older white women, and a lack of relatives or friendship ties for nonwhite women.
The Impact of Nurse Practitioner Attribution in Medicare Shared Savings ACOs
December 5th 2023Allowing nurse practitioners to serve as attribution-eligible providers for Medicare Shared Savings Program accountable care organizations leads to no change in hierarchical condition category risk scores and modest growth in attributed beneficiaries.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
What We’re Reading: UnitedHealth Lawsuit; Fentanyl Crackdown; Global Heat Deaths Increase
November 15th 2023A class action lawsuit was filed against UnitedHealth Group and a subsidiary for allegedly using an algorithm to deny rehabilitation coverage for seriously ill patients; US and China officials are finalizing an agreement to crack down on fentanyl; a study published Tuesday projected global heat deaths to increase by 370% if no action is taken against global warming.
Read More